Maxalt RPD 10 mg oralni liofilizati
Name | Maxalt RPD 10 mg oralni liofilizati |
---|---|
Marketing Authorisation Number | HR-H-455098518 |
Active Substance | rizatriptanbenzoat |
Composition | jedan oralni liofilizat sadrži 14,53 mg rizatriptanbenzoata (što odgovara 10 mg rizatriptana). |
Pharmaceutical Form | oralni liofilizat |
Manufacturer | Merck Sharp & Dohme B.V., Haarlem, Nizozemska |
Marketing Authorisation Holder | Organon Pharma d.o.o., Slavonska Avenija 1c, Zagreb, Hrvatska |
Marketing Authorisation Date | 09.08.2021 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/17-02/653 |
Registration Number | 381-12-01/154-21-14 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | N02CC04 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |